Interpretable Boosted Decision Trees for Prediction of Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation

R. Shouval, A. Nagler, M. Labopin, R. Unger
{"title":"Interpretable Boosted Decision Trees for Prediction of Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation","authors":"R. Shouval, A. Nagler, M. Labopin, R. Unger","doi":"10.4172/2153-0602.1000184","DOIUrl":null,"url":null,"abstract":"J Data Mining Genomics Proteomics ISSN: 2153-0602 JDMGP, an open access journal Volume 7 • Issue 1 • 1000184 Allogeneic (allo) hematopoietic stem transplantation (HSCT) is a potentially curative procedure for selected patients with hematological disease. Despite a reduction in transplant risk in recent years, morbidity and mortality remains substantial, making the decision of whom, how and when to transplant, of great importance [1].","PeriodicalId":15630,"journal":{"name":"Journal of Data Mining in Genomics & Proteomics","volume":"30 1 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Data Mining in Genomics & Proteomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2153-0602.1000184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

J Data Mining Genomics Proteomics ISSN: 2153-0602 JDMGP, an open access journal Volume 7 • Issue 1 • 1000184 Allogeneic (allo) hematopoietic stem transplantation (HSCT) is a potentially curative procedure for selected patients with hematological disease. Despite a reduction in transplant risk in recent years, morbidity and mortality remains substantial, making the decision of whom, how and when to transplant, of great importance [1].
异体造血干细胞移植后死亡率预测的可解释增强决策树
同种异体(allo)造血干细胞移植(HSCT)是一种治疗特定血液病患者的潜在方法。尽管近年来移植风险有所降低,但发病率和死亡率仍然很高,因此决定移植的对象、方式和时间非常重要[1]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信